Annals of internal medicine
-
Randomized Controlled Trial Multicenter Study
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
Primary Sjögren syndrome (pSS) is an autoimmune disorder characterized by ocular and oral dryness or systemic manifestations. ⋯ Rituximab did not alleviate symptoms or disease activity in patients with pSS at week 24, although it alleviated some symptoms at earlier time points.